NAYA Biosciences Inc
NASDAQ:NAYA
NAYA Biosciences Inc
Other Non-Cash Items
NAYA Biosciences Inc
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
NAYA Biosciences Inc
NASDAQ:NAYA
|
Other Non-Cash Items
$3.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Non-Cash Items
$16m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
-19%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Non-Cash Items
$676m
|
CAGR 3-Years
47%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
25%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Non-Cash Items
$1.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
27%
|
CAGR 10-Years
3%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Non-Cash Items
$1.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Non-Cash Items
$604.6m
|
CAGR 3-Years
10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
12%
|
|
NAYA Biosciences Inc
Glance View
INVO BioScience, Inc. is a fertility company. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. The Company’s initial pipeline includes two novel Flex-NK Bispecific Antibodies. NY-303: its GPC3-targeted FLEX-NK Bispecific Antibody for Hepatocellular Carcinoma (HCC). NY-338: its CD38-targeted FLEX-NK Bispecific Antibody for Multiple Myeloma (MM) & Autoimmune Diseases. Its lead GPC3-targeting FLEX-NK bispecific antibody is entering Phase I/II clinical trials and positioned as a monotherapy option to address the unmet needs of the of hepatocellular carcinoma (HCC) patients not responding to standard of care with checkpoint inhibitors. INVOcell is its novel, FDA-cleared and CE-marked intravaginal culture (IVC) device. The company offers a viable alternative to vitro fertilization (IVF) that uses the female body for fertilization and incubation, keeping women at the center of the reproductive process.
See Also
What is NAYA Biosciences Inc's Other Non-Cash Items?
Other Non-Cash Items
3.2m
USD
Based on the financial report for Sep 30, 2024, NAYA Biosciences Inc's Other Non-Cash Items amounts to 3.2m USD.
What is NAYA Biosciences Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
25%
Over the last year, the Other Non-Cash Items growth was 18%. The average annual Other Non-Cash Items growth rates for NAYA Biosciences Inc have been -15% over the past three years , 25% over the past five years .
You don't have any saved screeners yet